Comparison of cellular characteristics between human hepatoma cell lines with wild-type p53 and those with mutant-type p53 gene

被引:0
作者
Pu, H
Tsuji, T
Kondo, A
Fushimi, K
Ohashi, R
Inoue, Y
Mimura, T
Hamazaki, K
Miyazaki, M
Namba, M [1 ]
机构
[1] Okayama Univ, Sch Med, Inst Cellular & Mol Biol, Dept Cell Biol, Okayama 700, Japan
[2] Okayama Saiseikai Gen Hosp, Dept Surg, Okayama 700, Japan
[3] Kurashiki Med Ctr, Kurashiki, Okayama 710, Japan
关键词
hepatoma; p53; p21; p16; p27; Rb; TNF-alpha;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Characteristics of human hepatoma cell lines with the wild-type p53 were compared with those of human hepatoma cell lines with the mutant-type p53. The p21 protein located downstream of p53 was expressed in cell lines with the wildtype p53 but was not expressed in cell lines with the mutant-type p53. As to other tumor suppressor genes such as p16 and p27, there was no difference in their expression between both types of cell lines. In addition, no marked difference was observed in the activities of CDK2 and CDK4 between cell lines with the wild-type and the mutant-type p53. Phosphorylated Rb protein was detected in all cell lines except the HLE line, indicating that this cell line may have a deletion of and/or a mutation of the Rb gene. These results indicate that abnormalities of tumor suppressor genes other than p53, p16, p27, and Rb may be involved in hepatocarcinogenesis. The population doubling time of the wildtype p53 cells was significantly longer than that of the mutant p53 cells. Neither type of cell line showed a specific chromosome distribution which would indicate karyotype instability. The cell lines expressing the wild-type p53 produced tumors at lower frequency than those with the mutant p53 gene. Although there was no significant difference in effects of TGF-beta 1, EGF, cholera toxin, and db-cAMP on cell growth between the two types of cells, all three cell lines with the wildtype p53 were resistant to cytotoxicity of TNF-alpha, while two of the three with the mutant p53 were very sensitive to its cytotoxic effects.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 50 条
  • [31] Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53
    Sugikawa, E
    Yazaki, N
    Tsunoda, S
    Nakanishi, N
    Ohashi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 256 - 263
  • [32] WILD-TYPE P53 SUPPRESSES THE MALIGNANT PHENOTYPE IN BREAST-CANCER CELLS CONTAINING MUTANT P53 ALLELES
    RUNNEBAUM, IB
    YEE, JK
    KIEBACK, DG
    SUKUMAR, S
    FRIEDMANN, T
    ANTICANCER RESEARCH, 1994, 14 (3A) : 1137 - 1144
  • [33] Induction of apoptosis by cytoplasmically localized wild-type p53 and the S121F mutant super p53
    Yasuda, Katsuhiro
    Kato, Shunsuke
    Sakamoto, Yasuhiro
    Watanabe, Gou
    Mashiko, Satsuki
    Sato, Atsuko
    Kakudo, Yuichi
    Ishioka, Chikashi
    ONCOLOGY LETTERS, 2012, 3 (05) : 978 - 982
  • [34] MicroRNAs, wild-type and mutant p53 More questions than answers
    Jones, Matthew Fletcher
    Lal, Ashish
    RNA BIOLOGY, 2012, 9 (06) : 781 - 791
  • [35] Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells
    Maeda, T
    Matsubara, H
    Koide, Y
    Sugaya, M
    Miyazawa, Y
    Tasaki, K
    Isono, K
    Ochiai, T
    Sakiyama, S
    Tagawa, M
    ANTICANCER RESEARCH, 2000, 20 (2A) : 869 - 874
  • [36] Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
    Zhang, Shengliang
    Carlsen, Lindsey
    Hernandez Borrero, Liz
    Seyhan, Attila A.
    Tian, Xiaobing
    El-Deiry, Wafik S.
    BIOMOLECULES, 2022, 12 (04)
  • [37] Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment
    Atencio, IA
    Avanzini, JB
    Johnson, D
    Neuteboom, S
    Vaillancourt, MT
    Nielsen, LL
    Hajian, G
    Sutjipto, S
    Sugarman, BJ
    Philopena, J
    McAllister, DL
    Beltran, JC
    Nodelman, M
    Ramachandra, M
    Wills, KN
    MOLECULAR THERAPY, 2001, 4 (01) : 5 - 12
  • [38] Wild-type p53 gene transfection in human cultured sarcomas:: Effect of CDDP
    Endo, K
    Kuratate, I
    Watanabe, M
    Yoshida, H
    Teshima, R
    Osaki, M
    Ito, H
    ONCOLOGY REPORTS, 2001, 8 (03) : 637 - 642
  • [39] Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity
    Moore, Lynette
    Lu, Xiongbin
    Ghebranious, Nader
    Tyner, Stuart
    Donehower, Lawrence A.
    MECHANISMS OF AGEING AND DEVELOPMENT, 2007, 128 (11-12) : 717 - 730
  • [40] EFFECTS OF P53 MUTANTS ON WILD-TYPE P53-MEDIATED TRANSACTIVATION ARE CELL-TYPE DEPENDENT
    FORRESTER, K
    LUPOLD, SE
    OTT, VL
    CHAY, CH
    BAND, V
    WANG, XW
    HARRIS, CC
    ONCOGENE, 1995, 10 (11) : 2103 - 2111